Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.3K27M-Mutated Glioma
Clinical trial NCT05478837 · TERMINATED
Trial details
- NCT number
- NCT05478837
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-20
- Primary completion
- 2026-01-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.